HIV Tropism and Decreased Risk of Breast Cancer

• Nancy A. Hessol,

  Affiliation Department of Clinical Pharmacy, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Laura A. Napolitano,

  Affiliations Monogram Biosciences, South San Francisco, California, United States of America, Department of Medicine, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Dawn Smith,

  Affiliation Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Yolanda Lie,

  Affiliation Monogram Biosciences, South San Francisco, California, United States of America

  ⨯
• Alexandra Levine,

  Affiliations City of Hope National Medical Center, Duarte, California, United States of America, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America

  ⨯
• Mary Young,

  Affiliation Georgetown University School of Medicine, Washington D.C., United States of America

  ⨯
• Mardge Cohen,

  Affiliation Departments of Medicine, Stroger Hospital and Rush University, Chicago, Illinois, United States of America

  ⨯
• Howard Minkoff,

  Affiliation Maimonides Medical Center and State University of New York, Health Sciences Center at Brooklyn, Brooklyn, New York, United States of America

  ⨯
• Kathryn Anastos,

  Affiliation Montefiore Medical Center, Bronx, New York, United States of America

  ⨯
• Gypsyamber D'Souza,

  Affiliation Johns Hopkins School of Public Health, Baltimore, Maryland, United States of America

  ⨯
• Ruth M. Greenblatt,

  Affiliation Department of Clinical Pharmacy, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• James J. Goedert

  * E-mail: goedertj@mail.nih.gov

  Affiliation Infections & Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland, United States of America

  ⨯